JDM Financial Group »

Quince Therapeutics shares owned by JDM Financial Group

Quarter-by-quarter ownership of Quince Therapeutics shares owned by JDM Financial Group from 13F filings

Historical chart of JDM Financial Group investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by JDM Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by JDM Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $18 1 18.00

More positions owned by JDM Financial Group

Bny Mellon Us Large Cap Core Equity Etf Etf (BKLC)
State Street Spdr Portfolio Developed World Ex-us Etf Etf (SPDW)
Bondbloxx Bloomberg Six Month Target Duration Us Treasury Etf Etf (XHLF)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Vanguard S&p 500 Etf Etf (VOO)
Ishares S&p 500 Index Etf (IVV)
Vanguard Small-cap Etf Etf (VB)
Vanguard Mid Cap Etf (VO)
State Street Spdr Portfolio Emerging Markets Etf Etf (SPEM)
Vanguard Reit Index Etf Etf (VNQ)
State Street Spdr S&p 500 Etf Etf (SPY)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Vanguard Ftse Developed Markets Etf Etf (VEA)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Apple Stock (AAPL)

View all positions for JDM Financial Group

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Ikarian Capital
Millennium Management
Balyasny Asset Management
Susquehanna International
Squadron Capital Management
Shay Capital
Boothbay Fund Management
Jane Street
Vanguard Capital Management
Cormorant Asset Management
UBS Group
Vanguard Fiduciary Trust
BlackRock
Tower Research Capital

View all funds holding Quince Therapeutics